Screener
Integra LifeSciences IART EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Integra LifeSciences’s reported figures.
Based on trailing twelve months.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
FAQ
- What is Integra LifeSciences's EBITDA margin?
- Integra LifeSciences (IART) reported EBITDA margin of 12.8% in Q2 2026.
- How has Integra LifeSciences's EBITDA margin changed year-over-year?
- Integra LifeSciences's EBITDA margin increased by 161.6% year-over-year, from -20.8% to 12.8%.
- What is the long-term trend for Integra LifeSciences's EBITDA margin?
- Over 5 years (2020 to 2025), Integra LifeSciences's EBITDA margin has grown at a 0.9% compound annual growth rate (CAGR), from 20.4% to -21.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Integra LifeSciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude